Alyeska Investment Group, L.P. Context Therapeutics Inc. Put Options Transaction History
Alyeska Investment Group, L.P.
- $25.4 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding CNTX
# of Institutions
43Shares Held
76.2MCall Options Held
0Put Options Held
0-
Bio Impact Capital LLC Cambridge, MA14.7MShares$10 Million1.9% of portfolio
-
Avidity Partners Management LP Dallas, TX7.48MShares$5.08 Million1.33% of portfolio
-
Deep Track Capital, LP Greenwich, CT7.42MShares$5.05 Million0.17% of portfolio
-
Nextech Invest, Ltd. Zurich, V87.42MShares$5.05 Million0.92% of portfolio
-
Nextech Invest Ag7.42MShares$5.05 Million1.37% of portfolio
About Context Therapeutics Inc.
- Ticker CNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,966,100
- Market Cap $10.9M
- Description
- Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therape...